Guided Therapeutics (GTHP) Preferred Shares (2013 - 2025)

Guided Therapeutics has disclosed Preferred Shares across 13 years of filings, most recently posting $18000.0 for Q4 2025.

• Preferred Shares for Q4 2025 came in at $18000.0, down 89.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $18000.0 (down 89.41% YoY), and the FY2025 annual result was $18000.0, down 89.41% from the prior year.
• Preferred Shares came in at $18000.0 for Q4 2025 at Guided Therapeutics, down from $32000.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $1.6 million in Q4 2021 to a low of $18000.0 in Q4 2025.
• The 5-year median for Preferred Shares is $475000.0 (2023), against an average of $471684.2.
• Across the five-year window, Preferred Shares jumped 698.1% in 2023 and tumbled 93.26% in 2025, its largest moves.
• Guided Therapeutics' Preferred Shares stood at $1.6 million in 2021, then slumped by 70.16% to $489000.0 in 2022, then soared by 71.37% to $838000.0 in 2023, then tumbled by 79.71% to $170000.0 in 2024, then tumbled by 89.41% to $18000.0 in 2025.
• The last three Preferred Shares figures came in at $18000.0 (Q4 2025), $32000.0 (Q2 2025), and $61000.0 (Q1 2025), per Business Quant data.